CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,616,882
- in 14 filings, $3.0M under 10b5-1 plans
Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Schundler Russell General Counsel | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,344 | 18,750 | ||
| 2024-03-15 | Kaseta Michael CFO and COO | Exercise or conversion 10b5-1 | +2,344 | 330,347 | ||
| 2024-03-15 | Kaseta Michael CFO and COO | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,344 | 18,750 | ||
| 2024-02-29 | Moomaw Scott Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,875 | 160,120 | ||
| 2024-02-29 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −546 | $14.17 | $8K | 159,574 |
| 2024-02-29 | Moomaw Scott Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,875 | 15,000 | ||
| 2024-02-29 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +1,562 | 97,867 | ||
| 2024-02-29 | Adair Jason Chief Business Officer | Sale 10b5-1 | −455 | $14.17 | $6K | 97,412 |
| 2024-02-29 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,562 | 12,500 | ||
| 2024-01-15 | Kaseta Michael CFO and COO | Grant or award | +50,000 | 326,250 | ||
| 2024-01-11 | Schundler Russell General Counsel | Grant or award | +110,135 | 492,611 | ||
| 2024-01-11 | Schundler Russell General Counsel | Grant or award · Performance Stock Units | +60,135 | 60,135 | ||
| 2024-01-11 | Saggar Rajeev Chief Medical Officer | Grant or award | +56,492 | 220,591 | ||
| 2024-01-11 | Saggar Rajeev Chief Medical Officer | Grant or award · Performance Stock Units | +56,492 | 56,492 | ||
| 2024-01-11 | Moomaw Scott Chief Commercial Officer | Grant or award | −49,723 | 156,460 | ||
| 2024-01-11 | Moomaw Scott Chief Commercial Officer | Grant or award · Performance Stock Units | −49,723 | 49,723 | ||
| 2024-01-11 | Kaseta Michael CFO and COO | Grant or award | +93,250 | 276,250 | ||
| 2024-01-11 | Kaseta Michael CFO and COO | Grant or award · Performance Stock Units | −93,250 | 93,250 | ||
| 2024-01-11 | Adair Jason Chief Business Officer | Grant or award | +39,588 | 94,520 | ||
| 2024-01-11 | Adair Jason Chief Business Officer | Grant or award · Performance Stock Units | +39,588 | 39,588 |
Page 34 of 39 · 771 trades